Key facts
| Price (PPV) | 133 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | valsartanhydrochlorothiazide |
| Class | Agents acting on the renin-angiotensin system |
| ATC code | C09DA03 |
| Manufacturer | NOVOPHARMA |
| Presentation | Boite de 30 |
| Hospital price | 83.20 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement de l’hypertension artérielle essentielle chez l’adulte. L' association Valsartan-hydrochlorothiazide à dose fixe, est indiquée chez les patients dont la pression artérielle n’est pas suffisamment contrôlée par le valsartan ou l’hydrochlorothiazide en monothérapie.
Find an open pharmacy
On-call pharmacies near you
About Novosar Plus 160 mg / 25 mg
Novosar Plus 160 mg / 25 mg belongs to the agents acting on the renin-angiotensin system therapeutic class. In Morocco, this drug is marketed by NOVOPHARMA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Novosar Plus 160 mg / 25 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Novosar Plus 160 mg / 25 mg
Answers to common questions from Moroccan patients about this drug.